KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Common Equity (2016 - 2025)

Astrana Health's Common Equity history spans 15 years, with the latest figure at $789.1 million for Q3 2025.

  • For Q3 2025, Common Equity rose 11.99% year-over-year to $789.1 million; the TTM value through Sep 2025 reached $789.1 million, up 11.99%, while the annual FY2024 figure was $716.7 million, 16.23% up from the prior year.
  • Common Equity for Q3 2025 was $789.1 million at Astrana Health, up from $771.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $789.1 million in Q3 2025 and bottomed at $349.7 million in Q1 2021.
  • The 5-year median for Common Equity is $569.8 million (2023), against an average of $581.7 million.
  • The largest annual shift saw Common Equity surged 94.65% in 2021 before it grew 11.99% in 2025.
  • A 5-year view of Common Equity shows it stood at $454.1 million in 2021, then increased by 19.86% to $544.3 million in 2022, then rose by 13.29% to $616.7 million in 2023, then increased by 16.23% to $716.7 million in 2024, then rose by 10.09% to $789.1 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Common Equity are $789.1 million (Q3 2025), $771.5 million (Q2 2025), and $750.4 million (Q1 2025).